Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial
Clinical trial NCT03374202 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03374202
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2026-08-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.